Positive Expiratory Pressure Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Positive expiratory pressure therapy (PEP) is used for airway clearance therapy. In this therapy, a person breathes through a handheld mouthpiece or mask. This helps air to get behind the mucus in the lungs and move it from the airway walls. The device allows air to pass freely, and involves active expiration of the inhaled air against the resistance.
MARKET DYNAMICS
The positive expiratory pressure devices market is driving due to rise in prevalence of COPD owing to the increase in smoking and drinking in developed countries, and the recent launches of novel oscillatory PEP. However, lack of awareness about technologically advanced airway clearance therapies in low-income countries is expected to hamper the growth of the global Positive Expiratory Pressure Devices market. Moreover, time consuming traditional methods of airway clearance is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Positive Expiratory Pressure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of positive expiratory pressure devices market with detailed market segmentation by product type, pressure type, application, and end user. The positive expiratory pressure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in positive expiratory pressure devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The positive expiratory pressure devices market is segmented on the basis of product type, pressure type, application, and distribution channel. On the basis of product type, the market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. Based on pressure type, the global positive expiratory pressure device market is segmented into high pressure PEP (26-102cm H2O) and low-pressure PEP (5-20cm H2O). On the basis of application, the market is segmented into atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD. On the basis of end user, the market is segmented into hospital and clinics, ambulatory surgical centers, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the positive expiratory pressure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The positive expiratory pressure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting positive expiratory pressure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the positive expiratory pressure devices market in these regions.
By Product Type
By Pressure Type [High Pressure PEP
By Application
By End User
MARKET PLAYERS
The report covers key developments in the positive expiratory pressure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from positive expiratory pressure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for positive expiratory pressure devices market in the global market. Below mentioned is the list of few companies engaged in the Positive Expiratory Pressure Devices market.
The report also includes the profiles of key players in positive expiratory pressure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Positive expiratory pressure therapy (PEP) is used for airway clearance therapy. In this therapy, a person breathes through a handheld mouthpiece or mask. This helps air to get behind the mucus in the lungs and move it from the airway walls. The device allows air to pass freely, and involves active expiration of the inhaled air against the resistance.
MARKET DYNAMICS
The positive expiratory pressure devices market is driving due to rise in prevalence of COPD owing to the increase in smoking and drinking in developed countries, and the recent launches of novel oscillatory PEP. However, lack of awareness about technologically advanced airway clearance therapies in low-income countries is expected to hamper the growth of the global Positive Expiratory Pressure Devices market. Moreover, time consuming traditional methods of airway clearance is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Positive Expiratory Pressure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of positive expiratory pressure devices market with detailed market segmentation by product type, pressure type, application, and end user. The positive expiratory pressure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in positive expiratory pressure devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The positive expiratory pressure devices market is segmented on the basis of product type, pressure type, application, and distribution channel. On the basis of product type, the market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. Based on pressure type, the global positive expiratory pressure device market is segmented into high pressure PEP (26-102cm H2O) and low-pressure PEP (5-20cm H2O). On the basis of application, the market is segmented into atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD. On the basis of end user, the market is segmented into hospital and clinics, ambulatory surgical centers, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the positive expiratory pressure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The positive expiratory pressure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting positive expiratory pressure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the positive expiratory pressure devices market in these regions.
Positive Expiratory Pressure Devices Market Report Analysis
Positive Expiratory Pressure Devices Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Smiths Medical
- Aptalis Pharma US, Inc.
- Koninklijke Philips N.V.
- Monaghan Medical Corporation
- D
- R BURTON HEALTHCARE
- AirPhysio
- PARI GmbH
- CEGLA Medizintechnik
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product Type
- Face Mask PEP Devices
- Mouthpiece PEP Devices
- Bottle PEP Devices
By Pressure Type [High Pressure PEP
- 26-102cm H2O
- Low-Pressure PEP
By Application
- Atelectasis
- Bronchiectasis
- Bronchitis
- Cystic Fibrosis
- Asthma
- COPD
By End User
- Hospital And Clinics
- Ambulatory Surgical Centers
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the positive expiratory pressure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from positive expiratory pressure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for positive expiratory pressure devices market in the global market. Below mentioned is the list of few companies engaged in the Positive Expiratory Pressure Devices market.
The report also includes the profiles of key players in positive expiratory pressure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Smiths Medical
- Aptalis Pharma US, Inc.
- Koninklijke Philips N.V.
- Monaghan Medical Corporation
- D- R BURTON HEALTHCARE
- AirPhysio
- PARI GmbH
- CEGLA Medizintechnik
- WyMedical Pty Ltd
- Medica Holdings, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Positive Expiratory Pressure Devices Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Smiths Medical
2. Aptalis Pharma US, Inc.
3. Koninklijke Philips N.V.
4. Monaghan Medical Corporation
5. D- R BURTON HEALTHCARE
6. AirPhysio
7. PARI GmbH
8. CEGLA Medizintechnik
9. WyMedical Pty Ltd
10. Medica Holdings, Inc.
1. Smiths Medical
2. Aptalis Pharma US, Inc.
3. Koninklijke Philips N.V.
4. Monaghan Medical Corporation
5. D- R BURTON HEALTHCARE
6. AirPhysio
7. PARI GmbH
8. CEGLA Medizintechnik
9. WyMedical Pty Ltd
10. Medica Holdings, Inc.
Get Free Sample For